Indraprastha Medical Corporation Ltd
NSE: INDRAMEDCO BSE: 532150
₹417.80
(-3.21%)
Sat, 14 Feb 2026, 00:33 am
Market Cap39.58B
PE Ratio20.94
Dividend1.04
Health Services
Hospital/Nursing Management
24.5KIndraprastha Medical Corporation Analysis
dividend
- Unable to calculate sustainability of dividends as Indraprastha Medical has not reported any payouts.
- Unable to evaluate Indraprastha Medical's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Indraprastha Medical's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Indraprastha Medical is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Indraprastha Medical is profitable, therefore cash runway is not a concern.
- Indraprastha Medical is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (2174.9%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 35.6x debt.
- Indraprastha Medical's cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (25.7% vs 1.5% today).
- Interest payments on debt are well covered by earnings (EBIT is 9x coverage).
- Indraprastha Medical's level of debt (1.5%) compared to net worth is satisfactory (less than 40%).
- High level of physical assets or inventory.
management
- The tenure for the Indraprastha Medical board of directors is about average.
- P.'s remuneration is lower than average for companies of similar size in India.
- P.'s compensation has been consistent with company performance over the past year, both up more than 20%.
- The tenure for the Indraprastha Medical management team is about average.
misc
- Indraprastha Medical is not covered by any analysts.
- Indraprastha Medical has significant price volatility in the past 3 months.
past
- Indraprastha Medical's 1-year earnings growth exceeds its 5-year average (53.4% vs 4.5%)
- Indraprastha Medical's year on year earnings growth rate has been positive over the past 5 years.
- Indraprastha Medical used its assets more efficiently than the IN Healthcare industry average last year based on Return on Assets.
- Indraprastha Medical's earnings growth has exceeded the IN Healthcare industry average in the past year (53.4% vs 14.4%).
- Indraprastha Medical's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
- Indraprastha Medical has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
value
- Indraprastha Medical's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Indraprastha Medical's share price is below the future cash flow value, and at a substantial discount (> 40%).
- Indraprastha Medical is good value based on assets compared to the IN Healthcare industry average.
- Indraprastha Medical is good value based on earnings compared to the IN Healthcare industry average.
- Indraprastha Medical is good value based on earnings compared to the India market.
- INDRAMEDCO outperformed the Market in India which returned -14.5% over the past year.
- INDRAMEDCO underperformed the Healthcare industry which returned 9.1% over the past year.
- NSEI:INDRAMEDCO is up 4.3% underperforming the Healthcare industry which returned 5.4% over the past month.
- NSEI:INDRAMEDCO is up 4.3% underperforming the market in India which returned 8% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800